Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_assertion type Assertion NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_head.
- NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_provenance.
- NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_assertion evidence source_evidence_literature NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_provenance.
- NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_assertion SIO_000772 21942912 NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_provenance.
- NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_assertion wasDerivedFrom befree-20140225 NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_provenance.
- NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_assertion wasGeneratedBy ECO_0000203 NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_provenance.